Patent Assignment
Reel/Frame 059809/0557
Change of Name
Recorded: 2022-04-27
Pages: 6
Assignor
SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Executed: 2022-04-01
Assignee
SUMITOMO PHARMA ONCOLOGY, INC.
640 MEMORIAL DRIVE, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(44)
Substituted N-Phenylpyrimidin-2-Amine Analogs as Inhibitors of the Axl Kinase
PKM2 Modulators and Methods for Their Use
Predicting Response to Alvocidib by Mitochondrial Profiling
Alvocidib Prodrugs Having Increased Bioavailability
PKM2 Modulators and Methods for Their Use
Alvocidib Prodrugs Having Increased Bioavailability
Combination Therapies for Treatment of Cancer
Profiling Peptides and Methods for Sensitivity Profiling
Profiling Peptides and Methods for Sensitivity Profiling
Predicting Response to Alvocidib by Mitochondrial Profiling
PKM2 Modulators and Methods for Their Use
Profiling Peptides and Methods for Sensitivity Profiling
Alvocidib Prodrugs Having Increased Bioavailability
Axl Kinase Inhibitors and Use of the Same
Patent:
11,013,741 →
Application:
16/376,452 →
Predicting Response to Alvocidib by Mitochondrial Profiling
Alvocidib Prodrugs and Their Use as Protein Kinase Inhibitors
PKM2 Modulators and Methods for Their Use
Treatment Regimen for Cancers That Are Insensitive to Bcl-2 Inhibitors Using the Mcl-1 Inhibitor Alvocidib
Combination Therapies for Treatment of Cancer
CDK9 Inhibitors and Polymorphs Thereof for Use as Agents for Treatment of Cancer
Methods to Target Transcriptional Control at Super-Enhancer Regions
Application:
16/730,810 →
Publication:
US 2020/0316084
PKM2 Activators in Combination with Reactive Oxygen Species for Treatment of Cancer
Application:
16/755,868 →
Publication:
US 2020/0237766
Combination Therapies for Treatment of Cancer
Compositions Comprising PKM2 Modulators and Methods of Treatment Using the Same
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
PKM2 Modulators and Methods for Their Use
Application:
16/930,254 →
Publication:
US 2021/0002233
Materials and Methods for Treating Cancer
Application:
17/045,411 →
Publication:
US 2021/0145830
Combination Therapies for Treatment of Cancer
Application:
17/061,821 →
Publication:
US 2021/0228582
Axl Kinase Inhibitors and Use of the Same
CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of Cancer
Deuterated Alvocidib and Alvocidib Prodrugs
Application:
17/253,603 →
Publication:
US 2021/0277037
Methods for Monitoring Tumor Lysis Syndrome
Application:
17/284,409 →
Publication:
US 2021/0379042
Alvocidib Prodrugs Having Increased Bioavailability
Treatment of Acute Myeloid Leukemia (AML) with Venetoclax Failure
PKM2 Modulators and Methods for Their Use
Application:
17/439,611 →
Publication:
US 2022/0162200
Methods for Treating Castration-Resistant and Castration-Sensitive Prostate Cancer
Application:
17/547,799 →
Publication:
US 2022/0339172
Treatment of Cancer
Application:
17/596,805 →
Publication:
US 2022/0305037
Treatment of Cancer
Application:
17/596,807 →
Publication:
US 2022/0257581
Axl Inhibitor Formulations
Application:
17/761,993 →
Publication:
US 2022/0380348
Alk-5 Inhibitors and Uses Thereof
Application:
63/166,610 →
Alk-5 Inhibitors and Uses Thereof
Application:
63/166,621 →
(Furopyrimidin-4-yl)piperazine Compounds and Uses Thereof
Application:
63/166,852 →
Alk-5 Inhibitors and Uses Thereof
Application:
63/215,122 →
Imidazo[1,2-B]Pyridazinyl Compounds and Uses Thereof
Application:
63/227,579 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 15, 2013
From: BEARSS, DAVID J.; VANKAYALAPATI, HARIPRASAD; MOLLARD, ALEXIS; WARNER, STEVEN L.
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 031021/0171 →
Assignment of Assignor's Interest
Nov 10, 2015
From: HO, KOC-KAN; XU, YONG; SAUNDERS, MICHAEL DAVID; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 037005/0571 →
Assignment of Assignor's Interest
Aug 5, 2016
From: SIDDIQUI-JAIN, ADAM; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 039358/0432 →
Assignment of Assignor's Interest
Aug 31, 2016
From: WARNER, STEVEN L.; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 039601/0719 →
Security Interest
Nov 17, 2016
From: TOLERO PHARMACEUTICALS, INC.
To: SUMITOMO DAINIPPON PHARMA CO., LTD.
Reel/Frame 040362/0884 →
Assignment of Assignor's Interest
Mar 15, 2018
From: BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.; PETERSON, PETER W.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 045238/0259 →
Assignment of Assignor's Interest
Apr 24, 2018
From: BEARSS, DAVID J.; WARNER, STEVEN L.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 045626/0176 →
Assignment of Assignor's Interest
Dec 19, 2018
From: HO, KOC-KAN; XU, YONG; SAUNDERS, MICHAEL DAVID; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 047959/0693 →
Assignment of Assignor's Interest
Jan 17, 2019
From: BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.; PETERSON, PETER W.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 048379/0095 →
Assignment of Assignor's Interest
Jul 17, 2019
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049775/0631 →
Assignment of Assignor's Interest
Jul 17, 2019
From: SIDDIQUI-JAIN, ADAM
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049774/0387 →
Assignment of Assignor's Interest
Jul 17, 2019
From: SAWAYAMA, YUSUKE; HIROSE, WATARU; BAN, HITOSHI
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 049774/0933 →
Assignment of Assignor's Interest
Jul 17, 2019
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049775/0023 →
Assignment of Assignor's Interest
Jul 17, 2019
From: SIDDIQUI-JAIN, ADAM; WARNER, STEVEN L.; FLYNN, PAUL; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049775/0391 →
Assignment of Assignor's Interest
Jul 17, 2019
From: TOMIMATSU, NOZOMI; FUJIMURA, KEN; UMEHARA, HIROKI; NONOYAMA, AKIHITO
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 049775/0543 →
Assignment of Assignor's Interest
Aug 7, 2019
From: BEARSS, DAVID J.; SIDDIQUI-JAIN, ADAM; WHATCOTT, CLIFFORD J.; PETERSON, PETER W.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 049995/0266 →
Assignment of Assignor's Interest
Dec 23, 2019
From: SIDDIQUI-JAIN, ADAM; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051356/0527 →
Assignment of Assignor's Interest
Feb 19, 2020
From: WARNER, STEVEN L.; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051855/0587 →
Assignment of Assignor's Interest
Feb 21, 2020
From: WARNER, STEVEN L.; BEARSS, DAVID J.
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051883/0725 →
Assignment of Assignor's Interest
Apr 27, 2020
From: HO, KOC-KAN; XU, YONG; SAUNDERS, MICHAEL DAVID; LIU, XIAOHUI
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 052500/0057 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0713 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0705 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0684 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053181/0133 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053181/0114 →